Navigation Links
Interferon needed for cells to 'remember' how to defeat a virus, UT Southwestern researchers report
Date:12/2/2008

DALLAS Dec. 3, 2008 Scientists at UT Southwestern Medical Center have determined that the immune-system protein interferon plays a key role in "teaching" the immune system how to fight off repeated infections of the same virus.

The findings, available online and in the Dec. 15 issue of the Journal of Immunology, have potential application in the development of more effective vaccines and anti-viral therapies.

Typically, when a person is infected with a virus, the human body immediately generates a massive number of T cells a type of immune cell that kill off the infected cells. Once the infection has cleared, most of the T cells also die off, leaving behind a small pool of central memory cells that "remember" how to fight that particular type of virus if the person is infected again.

"In this study, we have uncovered interferon's role and the key signaling protein, called IL-2, involved in generating memory T cells," said Dr. David Farrar, assistant professor of immunology at UT Southwestern and senior author of the study. "Knowing how T cells acquire this memory may help us design better strategies and vaccines to fight HIV and other infectious diseases. Further, our discovery was made using primary human CD4+ T cells, which underscores the relevance of our discovery to human immune responses."

CD4+ T cells coordinate the actions of other cells at the site of infection.

When a virus or bacterium infects a human, the infected cells secrete several molecules, including a cytokine or signaling protein called interferon alpha. The action of interferon is what makes an infected person feel run down and tired. Although scientists knew that interferon alpha prevented a virus from multiplying and spreading, they didn't know what role interferon played in the creation of memory cells.

In the current study, the UT Southwestern researchers show that both interferon alpha and another signaling prot
'/>"/>

Contact: Kristen Holland Shear
kristen.hollandshear@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Only Half of MS Patients Respond to Interferon Therapy
2. Interferon Reduces, Eliminates Viral Infections in Heart Failure Patients
3. Study shows that high-dose, high-frequency interferon produces no additional benefit
4. GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
5. PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
6. Interferon does not slow or stop hepatitis C from worsening, study finds
7. Revised hours and workloads for medical residents needed to prevent
8. New survey: More than half of US chronically ill adults skip needed care due to costs
9. EMU School of Nursing Injects Much Needed Help Into Nursing Shortage
10. MSU doctors bring much-needed psychiatric care to rural areas via technology
11. Susan G. Komen for the Cure(R), Speaker Dennis OBrien, Obama and McCain Health Care Advisors, Breast Cancer Survivors and Advocates Call for Needed Health Care Reforms

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Interferon needed for cells to 'remember' how to defeat a virus, UT Southwestern researchers report
Interferon needed for cells to 'remember' how to defeat a virus, UT Southwestern researchers report
(Date:11/26/2009)..., PRINCETON, N.J., Nov. 27 The di... double over the next 25 years and annual medical ...illion, up from $113 billion today, according to a...s Care . The National Changing Diabetes ® P...oned the analysis by a team from the University of...
(Date:11/26/2009)...t,s too big or too heavy can lead to strains or wo...s) -- There may be nothing wrong with stuffing you...to do the same thing with your suitcase as you pac...were treated in 2008 in U.S. hospital emergency ro...acilities for luggage-related injuries, such as mu...
(Date:11/26/2009)... Dr. David Kim of the Live Life Agai... in Dallas , is one of a growing number of physici...tworking sites to connect with individuals who are...ight morbid obesity. Dr. Kim is utilizing Facebook...about his practice with the community. , ...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering...ers of Yaz and Yasmin birth control pills who have...Embolism, Stroke, Heart Attack or other related ca...en can call toll free at 1-800-856-6405 or go to t...m and fill out an online case evaluation form. ,...
(Date:11/25/2009)..., EMERYVILLE, Calif., Nov. 25 /PRNewswire-FirstCa... ) today announced that the company will host two ... ,, December 7, 2009 - 9:00 a.m. CT/10:00 a...s data presentations surrounding carfilzomib in re...ured at the 51st American Society of Hematology (A...
Breaking Medicine News(10 mins):Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...ican College of Allergy,Asthma & Immunology (ACAAI...merica surveys that highlight the importance of im...These survey findings and other important,informat...driving the dialogue about unmet needs for patient...
... 22 Medco Health,Solutions, Inc., (NYSE: MHS ) t...dHealth Group to provide pharmacy benefit services...ext generation of collaboration with,UnitedHealth ...p and includes new terms that provide clear alignm...
... To enhance absorption, the,Longevinex(R) matrix ...resveratrol, microencapsulated in an envelope of a... resveratrol in its trans-resveratrol form,from de...resveratrol matrix withstands direct,exposure to s...
...ERTIFICATION PROGRAM CONTINUES TO EXPAND IN THE ... April 22 More people than ever,before are buying...,standards -- especially people with asthma and al...ts and finishes from manufacturing or,packaging, a...
...onal Union files anti-SLAPP motion against,the Cal... vacate TRO,publicity stunt, OAKLAND, Calif., Apr...SEIU) today filed an anti-Strategic Lawsuit,to Pre...ivisive tactics. The motion cites a temporary rest...
...Jury Endorses Competition in the Durable Medical ...TTLE, April 21 Seattle law firm Williams Kastner,...ay in a business,litigation case involving claims ...man, Warren and Ruth Ann Hall and Halls,Drug Cente...
Other Medicine News:Health News:Medco, UnitedHealth Group Announce Pharmacy Services Agreement 2Health News:New: Longevinex(R) First to Introduce Micronized Resveratrol Matrix - Now Stabilized by Microencapsulation 2Health News:More Americans are Sleeping Thanks to Science 2Health News:SEIU Seeks Damages for CNA's Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics 2Health News:SEIU Seeks Damages for CNA's Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics 3Health News:SEIU Seeks Damages for CNA's Effort to Silence Workers, Suppress Criticism of Anti-Union Tactics 4
(Date:11/27/2009)..., BLOOMINGTON, Minn, Nov. 27 ACUO...cal image management software, data migration tool...ited States Patent and Trademark Office has approv...n Format within a Computer Network." Acuo Technolo...folio of intellectual property. In general, the gr...
(Date:11/25/2009)... , CANOGA PARK, Calif., Nov. 25 ...place rankings in the American Academy of Family P... 2009 EHR User Satisfaction Survey for improving m...nagement, all critical for new ARRA Stimulus legis...ting their EMR had a positive effect in determinin...
(Date:11/25/2009)... , BEDFORD, Mass., Nov. 25 /PRNewswire-FirstCa...daq: HOLX ), a leading developer, manufacturer an... systems and surgical products dedicated to servin...al meeting of the Radiological Society of North Am...er 29 through December 3, 2009 to highlight our ne...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4Lupus Research Institute announces 2009 novel research grants 10894 1Lupus Research Institute announces 2009 novel research grants 10894 2Lupus Research Institute announces 2009 novel research grants 10894 3Springer and the American College of Medical Toxicology to work together 10889 1Springer and the American College of Medical Toxicology to work together 10889 2Cholesterol Plays Role in Heart Failure Risk 62037 1Cholesterol Plays Role in Heart Failure Risk 62037 2
... VIENNA, Austria, June 11 /PRNewswire-FirstCall/,-...ed the publication of data,from the company,s posi...ea,vaccine in The Lancet. The study, which analyze...eived the Iomai patch-based vaccine were,statistic...ically,significant diarrhea than their counterpart...
...ter Presentation at the Associated Professional Sl...ing, BALTIMORE, June 11 Data was presented today...essional Sleep Societies (APSS),demonstrating that...), an,investigational low-dose, sublingual formula...y that was significantly greater than that produce...
Other Medicine Technology:Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 2Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 3Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 4Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 5Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 6Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 7Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose 2Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose 3Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose 4Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose 5
...ble, light weight, high power Erbium:YAG laser sys... plastic surgery, general surgery, ENT and ophthal... the smallest, yet among the most powerful, Erbium...eatment for younger patients with mild wrinkles or...
...d to induce interstitial laser coagulation or tiss...en used to induce interstitial laser coagulation, ...rgy to heat the targeted tissue to a temperature r...ow temperatures at which carbonization begins. Whe...
...ghly accurate measurements of intraocular pressure...ic for the diagnosis and treatment of glaucoma. H...-year National Institute of Health (NIH) study pub...ickness (CCT) is an important and necessary biomet...
Gonorrhea Swabs
Medicine Products: